Top Markets
Coin of the day
Scandion Oncology A/S Scandion Oncology A/S

Scandion Oncology A/S

SCOL
株式のランク #40630
Operating as a clinical-stage biotechnology company, Scandion Oncology A/S... Operating as a clinical-stage biotechnology company, Scandion Oncology A/S specializes in creating pharmaceutical solutions to combat resistance to chemotherapy. Their primary investigational drug, SCO-101, an orally administered compound, is currently progressing through Phase Ib and Phase II clinical studies with cancer patients. Another pipeline candidate, SCO-201, is undergoing preclinical assessment for its potential efficacy against solid tumors. Established in 2017, Scandion Oncology A/S maintains its headquarters in Copenhagen, Denmark.
株価
$0.00045794
最終同期: 2025-07-11
時価総額
$107.51K
変化(1日)
-36.01%
変化(1年)
0.00%
DK
取引 Scandion Oncology A/S (SCOL)

カテゴリー

Scandion Oncology A/S(SCOL)の株価履歴
終値の最高値: $0.00 (2025-07-01)

終値の最安値: $0.74 (2018-11-01)
Scandion Oncology A/S の株価履歴(2018 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2025 -92.13%
2024 -96.87%
2023 -14.41%
2022 -80.44%
2021 -42.28%
2020 127.83%
2019 80.43%
2018 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE